Clinical trials
Terminated Multiple Sclerosis trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 5 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 7 |
| Charite University, Berlin, Germany | 4 |
| Novartis Pharmaceuticals | 4 |
| Actelion | 1 |
| Avigen | 1 |
| Bayer | 1 |
| EMD Serono | 1 |
| GeNeuro SA | 1 |
| H. Lundbeck A/S | 1 |
| MedDay Pharmaceuticals SA | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 28 |
| Multiple Sclerosis, Relapsing-Remitting | 7 |
| Multiple Sclerosis, Chronic Progressive | 3 |
| Fatigue | 2 |
| Cognitive Dysfunction | 1 |
| Muscle Spasticity | 1 |
| Neoplasm Metastasis | 1 |
| Osteoporosis | 1 |
| Urinary Bladder, Overactive | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.